A Short Review of Coronary Artery Lesions in Children

HongPing Zhong

Department of Paediatrics, Yan’an University Affiliated Hospital, Yan’an 716000, China.

YaQing Zhang

Department of Paediatrics, Yan’an University Affiliated Hospital, Yan’an 716000, China.

FuYong Jiao *

Children's Hospital of Shaanxi Provincial People's Hospital, Kawasaki Disease Diagnosis and Treatment Center of Shaanxi Province, Xi'an, China.

*Author to whom correspondence should be addressed.


Abstract

Coronary artery lesions (CAL) are not uncommon in pediatrics, but their causesare complex, such as congenital coronary artery disease, atherosclerosis, infectious diseases, and rheumatic immune diseases, which can lead to CAL. This review provides a systematic evaluation of the published medical literature on potential etiologies and associated pathogenesis that may lead to CAL in children, in order to broaden clinical diagnosis and avoid misdiagnosis and underdiagnosis. The main pathogenesis of CAL is an innate immunity imbalance due to exposure of genetically susceptible people to various infections and/or environmental factors. Kawasaki disease is not the only cause of CAL, and pediatricians need to better understand the immunological mechanisms of the CAL to suspect and diagnose.In addition, attach great importance to rheumatic immune diseases and cardiovascular diseases secondary to CAL.

Keywords: Kawasaki disease, dyslipidemia, underdiagnosis, coronary artery injury


How to Cite

Zhong , HongPing, YaQing Zhang, and FuYong Jiao. 2023. “A Short Review of Coronary Artery Lesions in Children”. Asian Journal of Pediatric Research 12 (4):21-27. https://doi.org/10.9734/ajpr/2023/v12i4248.

Downloads

Download data is not yet available.

References

Islam AKM Monwarul, Majumder AAS. Coronary artery disease in Bangladesh: A review [J]. Indian Heart Journal. 2013; (4):424-35.

An Qi, Li Shoujun. Chinese expert consensus on surgical treatment of congenital heart disease (12): Congenital coronary artery abnormalities [J]. China Clinical Journal of Thoracic and Cardiovascular Surgery. 2020;27(12): 1375-1381.

Mccrindle Brian-W, Rowley Anne-H, Newburger Jane-W, et al. Diagnosis, treatment, and long-term management of kawasaki disease: A scientific statement for health professionals from the American heart association [J]. Circulation. 2017; (17):e927-e999.

Taichi Kato, Masaru Miura, Tohru Kobayashi, et al. Analysis of coronary arterial aneurysm regression in patients with kawasaki disease by aneurysm severity: Factors associated with regression [J]. Journal of the American Heart Association. 2023;12(3):e022417.

Mccrindle Brian-W, Manlhiot Cedric, Newburger Jane-W, et al. Medium-term complications associated with coronary artery aneurysms after kawasaki disease: A study from the international kawasaki disease registry [J]. Journal of the American Heart Association. 2020;(15): e016440.

Orenstein Jan-Marc, et al. Three linked vasculopathic processes characterize kawasaki disease: A light and transmission electron microscopic study [J]. Plos One. 2012;(6):e38998.

Kei Takahashi, Toshiaki Oharaseki, Yuki Yokouchi, et al. Kawasaki disease: Basic and pathological findings [J]. Clinical and Experimental Nephrology. 2012;17(5):690-693.

Sato Wakana, Yokouchi Yuki, Oharaseki Toshiaki, et al. The pathology of kawasaki disease aortitis: A study of 37 cases [J]. Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology. 2020:107303.

Yue-Hin Loke, Charles I Berul, Ashraf S Harahsheh. Multisystem inflammatory syndrome in children: Is there a linkage to kawasaki disease? [J] Trends in Cardiovascular Medicine. 2020;30(7):389-396.

Kaushik Ashlesha, Gupta Sandeep, Sood Mangla, et al. A systematic review of multisystem inflammatory syndrome in children associated with SARS- CoV-2 infection [J]. The Pediatric Infectious Disease Journal. 2020;(11): e340-e346.

Lee Min-Sheng, Liu Yi-Ching, Tsai Ching-Chung, et al. Similarities and differences between COVID-19-related multisystem inflammatory syndrome in children and kawasaki disease.[J]. Frontiers in Pediatrics. 2021:640118.

Cheung Eva-W, Zachariah Philip, Gorelik Mark, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City.[J]. JAMA. 2020;(3):294-296.

Jerin Jose, Elif Seda Selamet Tierney, Ashraf S Harahsheh, et al. COVID-19 positive versus negative complete kawasaki disease: A study from the international kawasaki disease registry.[J]. Pediatric Cardiology. 2023:1-9.

Alberto García-Salido, Juan Carlos de Carlos Vicente, Sylvia Belda Hofheinz, et al. Severe manifestations of SARS-CoV-2 in children and adolescents: From COVID-19 pneumonia to multisystem inflammatory syndrome: A multicentre study in pediatric intensive care units in Spain.[J]. Critical Care (London, England). 2020;24 (1):666.

Elizabeth Whittaker, Alasdair Bamford, Julia Kenny, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.[J]. JAMA. 2020;324(3):259-269.

Consiglio Camila-Rosat, Cotugno Nicola, Sardh Fabian, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19 [J]. Cell. 2020;(4):968-981.e7.

Conor N Gruber, Roosheel S Patel, Rebecca Trachtman, et al. Mapping systemic inflammation and antibody responses in Multisystem Inflammatory Syndrome in Children (MIS-C).[J]. Cell. 2020;183(4):982-995.e14.

Souza Alexandre-Wagner-Silva-de, Carvalho Jozélio-Freire-de. Diagnostic and classification criteria of Takayasu arteritis.[J]. Journal of Autoimmunity. 2014:79-83.

Seza Ozen, Angela Pistorio, Silvia M Iusan, et al. EULAR/PRINTO/PRES criteria for henoch-schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood takayasu arteritis: Ankara 2008. Part II: Final classification criteria.[J]. Annals of the Rheumatic Diseases. 2010;69(5):798-806.

Aeschlimann Florence A, Yeung Rae SM, Laxer Ronald M. An update on childhood-onset takayasu arteritis [J]. Frontiers in Pediatrics. 2022:872313.

Podgorska Dominika, Podgorski Rafal, Aebisher David, et al. Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment [J]. Journal of Applied Biomedicine. 2019;(1):20.

Aeschlimann Florence A, Twilt Marinka, Yeung Rae SM. Childhood-onset takayasu arteritis.[J]. European Journal of Rheumatology. 2020;(Suppl1):S58-S66.

Ravelli Angelo, Martini Alberto. Juvenile idiopathic arthritis.[J]. Lancet (London, England). 2007;(9563):767-778.

Erdal Sağ, Berna Uzunoğlu, Fatma Bal, et al. Systemic onset juvenile idiopathic arthritis: A single center experience [J]. The Turkish Journal of Pediatrics. 2019;61(6):852-858.

Kumar Sathish. Systemic juvenile idiopathic arthritis: Diagnosis and management [J]. Indian Journal of Pediatrics. 2016;(4):322-7.

Felix A, Delion F, Suzon B, et al. Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study.[J]. Pediatric Rheumatology Online Journal. 2022;20(1): 98.

Arsenaki Elisavet, Georgakopoulos Panagiotis, Mitropoulou Panagiota, et al. Cardiovascular disease in juvenile idiopathic arthritis [J]. Current Vascular Pharmacology. 2020;(6):580-591.

Saverio La Bella, Marta Rinaldi, Armando Di Ludovico, et al. Genetic background and molecular mechanisms of juvenile idiopathic arthritis.[J]. International Journal of Molecular Sciences. 2023;24(3).

Yu-Tsan Lin, et al. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis.[J]. Autoimmunity Reviews. 2011;10(8):482-9.

Silva Clovis-A, Avcin Tadej, Brunner Hermine I. Taxonomy for systemic lupus erythematosus with onset before adulthood [J]. Arthritis Care & Research. 2012;(12): 1787-93.

Ohara Asami, Iwata Naomi, Sugiura Shiro, et al. Evaluation of the European league against rheumatism/American College of rheumatology-2019 classification criteria in patients with childhood-onset systemic lupus erythematosus: A single-center retrospective study.[J]. Clinical Rheumatology. 2022;(8):2483-2489.

Shen CC, Chung HT, Huang YL, et al. Coronary artery dilation among patients with paediatric-onset systemic lupus erythematosus.[J]. Scandinavian Journal of Rheumatology. 2012;(6):458- 65.

Sherif M Gamal, Sally S Mohamed, Marwa Tantawy, et al. Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients.[J]. Archives of Rheumatology. 2021;36(4):595-692.

Agarwal Arunima, Student Stephanie-Biglarian-Medical, Lim-stavros Sophia, et al. Pediatric systemic lupus erythematosus presenting with coronary arteritis: A case series and review of the literature.[Z] 2015:42-7.

Khaled Z Abd-Elmoniem, Nadine Ramos, Saami K Yazdani, et al. Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.[J]. Atherosclerosis. 2017;258:20-25.

Alexandra F Freeman, Elizabeth Mannino Avila, Pamela A Shaw, et al. Coronary artery abnormalities in Hyper-IgE syndrome.[J]. Journal of Clinical Immunology. 2011;31(3):338-45.

Sandra Hansmann, Elke Lainka, Gerd Horneff, et al. Consensus protocols for the diagnosis and management of the hereditary auto inflammatory syndromes CAPS, TRAPS and MKD/HIDS: A German PRO-KIND initiative.[J]. Pediatric Rheumatology Online Journal. 2020;18(1): 17.

Ru-Yue Chen, Xiao-Zhong Li, Qiang Lin, et al. Epstein-barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked Inhibitor of Apoptosis Protein (XIAP) variant: A case report.[J]. Bmc Pediatrics, 2020;20(1):456.

Cohen Jeffrey I, Jaffe Elaine S, Dale Janet K, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: A 28-year experience in the United States.[J]. Blood. 2011;(22):5835-49.

Quintanilla-martinez Leticia, Swerdlow Steven H, Tousseyn Thomas, et al. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.[J]. Virchows Archiv: An International Journal of Pathology. 2022;(1):227-244.

Kimura Hiroshi, et al. Prognostic factors for chronic active epstein-barr virus infection.[J]. The Journal of Infectious Diseases. 2003;(4):527-33.

Muneuchi Jun, Ohga Shouichi, Ishimura Masataka, et al. Cardiovascular complications associated with chronic active epstein-barr virus infection.[Z] 2009: 274-81.

Correction to: Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.[J]. Circulation. 2019;(5):e181-e184.